# The risk of rifampicin-resistant TB after drug-susceptible TB treatment

**Authors:** A.N. Shapiro, H. Moultrie, K.R. Jacobson, J. Bor, P. da Silva, L. Scott, H.E. Jenkins

PMC · DOI: 10.5588/ijtldopen.24.0552 · IJTLD OPEN · 2025-03-12

## Full-text entities

- **Diseases:** TB (MESH:D014390)
- **Chemicals:** rifampicin (MESH:D012293)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11906027/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC11906027/full.md

---
Source: https://tomesphere.com/paper/PMC11906027